Israel Englander’s Carlyle Group CG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.9M Buy
+211,300
New +$9.92M ﹤0.01% 2405
2026
Q1
Sell
-8,200
Closed -$485K 5783
2025
Q4
$485K Sell
8,200
-19,400
-70% -$1.1M ﹤0.01% 4961
2025
Q3
$1.73M Sell
27,600
-16,700
-38% -$1.04M ﹤0.01% 4192
2025
Q2
$2.28M Sell
44,300
-9,400
-18% -$405K ﹤0.01% 3762
2025
Q1
$2.34M Buy
+53,700
New +$2.66M ﹤0.01% 3638
2022
Q2
Sell
-230,000
Closed -$11.2M 7015
2022
Q1
$11.2M Buy
+230,000
New +$11M 0.01% 2024

Other funds holding CG

Israel Englander's CG Position: Q2 2026 in Review

Israel Englander reduced its Carlyle Group (CG) stake by 97% in Q2 2026, selling an estimated $311M and leaving 178,458 shares worth $7.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

Israel Englander first reported a position in CG in Q3 2015 and has held it in 24 quarters since. The position peaked at $493M in Q4 2025. 583 funds tracked by Wall St. Rank hold CG as of Q2 2026.

  • Israel Englander held 178,458 shares of Carlyle Group worth $7.51M as of Q2 2026.
  • Israel Englander sold 6,624,597 Carlyle Group shares in Q2 2026, an estimated $311M.
  • Carlyle Group made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2597 holding.
  • Israel Englander first reported a position in Carlyle Group in Q3 2015 and has held it in 24 quarters since.
  • Israel Englander's Carlyle Group position peaked at $493M in Q4 2025.
  • 583 funds tracked by Wall St. Rank held Carlyle Group as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.